-
Je něco špatně v tomto záznamu ?
Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape
Q. Wu, L. You, E. Nepovimova, Z. Heger, W. Wu, K. Kuca, V. Adam
Jazyk angličtina Země Velká Británie
Typ dokumentu časopisecké články, přehledy
Grantová podpora
31972741
Natural Science Foundation of Jilin Province
2016T90477
Postdoctoral Science Foundation of Jiangsu Province
759585
H2020 European Research Council
NLK
BioMedCentral
od 2008-12-01
BioMedCentral Open Access
od 2008
Directory of Open Access Journals
od 2008
Free Medical Journals
od 2008
PubMed Central
od 2008
Europe PubMed Central
od 2008
ProQuest Central
od 2009-01-01
Open Access Digital Library
od 2008-01-01
Open Access Digital Library
od 2008-01-01
Medline Complete (EBSCOhost)
od 2009-01-17
Health & Medicine (ProQuest)
od 2009-01-01
ROAD: Directory of Open Access Scholarly Resources
od 2008
Springer Nature OA/Free Journals
od 2008-12-01
- MeSH
- faktor 1 indukovatelný hypoxií - podjednotka alfa MeSH
- hypoxie metabolismus MeSH
- imunitní dozor MeSH
- lidé MeSH
- nádorové mikroprostředí MeSH
- nádory * MeSH
- únik nádoru z imunitní kontroly * MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- přehledy MeSH
Hypoxia, a common feature of the tumor microenvironment in various types of cancers, weakens cytotoxic T cell function and causes recruitment of regulatory T cells, thereby reducing tumoral immunogenicity. Studies have demonstrated that hypoxia and hypoxia-inducible factors (HIFs) 1 and 2 alpha (HIF1A and HIF2A) are involved in tumor immune escape. Under hypoxia, activation of HIF1A induces a series of signaling events, including through programmed death receptor-1/programmed death ligand-1. Moreover, hypoxia triggers shedding of complex class I chain-associated molecules through nitric oxide signaling impairment to disrupt immune surveillance by natural killer cells. The HIF-1-galactose-3-O-sulfotransferase 1-sulfatide axis enhances tumor immune escape via increased tumor cell-platelet binding. HIF2A upregulates stem cell factor expression to recruit tumor-infiltrating mast cells and increase levels of cytokines interleukin-10 and transforming growth factor-β, resulting in an immunosuppressive tumor microenvironment. Additionally, HIF1A upregulates expression of tumor-associated long noncoding RNAs and suppresses immune cell function, enabling tumor immune escape. Overall, elucidating the underlying mechanisms by which HIFs promote evasion of tumor immune surveillance will allow for targeting HIF in tumor treatment. This review discusses the current knowledge of how hypoxia and HIFs facilitate tumor immune escape, with evidence to date implicating HIF1A as a molecular target in such immune escape. This review provides further insight into the mechanism of tumor immune escape, and strategies for tumor immunotherapy are suggested.
Central European Institute of Technology Brno University of Technology Brno 602 00 Czech Republic
College of Life Science Yangtze University Jingzhou 434025 China
Department of Chemistry and Biochemistry Mendel University in Brno Brno 613 00 Czech Republic
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018061
- 003
- CZ-PrNML
- 005
- 20220804134531.0
- 007
- ta
- 008
- 220720s2022 xxk f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1186/s13045-022-01292-6 $2 doi
- 035 __
- $a (PubMed)35659268
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxk
- 100 1_
- $a Wu, Qinghua $u College of Life Science, Yangtze University, Jingzhou, 434025, China $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 50003, Hradec Kralove, Czech Republic
- 245 10
- $a Hypoxia-inducible factors: master regulators of hypoxic tumor immune escape / $c Q. Wu, L. You, E. Nepovimova, Z. Heger, W. Wu, K. Kuca, V. Adam
- 520 9_
- $a Hypoxia, a common feature of the tumor microenvironment in various types of cancers, weakens cytotoxic T cell function and causes recruitment of regulatory T cells, thereby reducing tumoral immunogenicity. Studies have demonstrated that hypoxia and hypoxia-inducible factors (HIFs) 1 and 2 alpha (HIF1A and HIF2A) are involved in tumor immune escape. Under hypoxia, activation of HIF1A induces a series of signaling events, including through programmed death receptor-1/programmed death ligand-1. Moreover, hypoxia triggers shedding of complex class I chain-associated molecules through nitric oxide signaling impairment to disrupt immune surveillance by natural killer cells. The HIF-1-galactose-3-O-sulfotransferase 1-sulfatide axis enhances tumor immune escape via increased tumor cell-platelet binding. HIF2A upregulates stem cell factor expression to recruit tumor-infiltrating mast cells and increase levels of cytokines interleukin-10 and transforming growth factor-β, resulting in an immunosuppressive tumor microenvironment. Additionally, HIF1A upregulates expression of tumor-associated long noncoding RNAs and suppresses immune cell function, enabling tumor immune escape. Overall, elucidating the underlying mechanisms by which HIFs promote evasion of tumor immune surveillance will allow for targeting HIF in tumor treatment. This review discusses the current knowledge of how hypoxia and HIFs facilitate tumor immune escape, with evidence to date implicating HIF1A as a molecular target in such immune escape. This review provides further insight into the mechanism of tumor immune escape, and strategies for tumor immunotherapy are suggested.
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a hypoxie $x metabolismus $7 D000860
- 650 _2
- $a faktor 1 indukovatelný hypoxií - podjednotka alfa $7 D051795
- 650 _2
- $a imunitní dozor $7 D007157
- 650 12
- $a nádory $7 D009369
- 650 12
- $a únik nádoru z imunitní kontroly $7 D019139
- 650 _2
- $a nádorové mikroprostředí $7 D059016
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a You, Li $u College of Life Science, Yangtze University, Jingzhou, 434025, China
- 700 1_
- $a Nepovimova, Eugenie $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 50003, Hradec Kralove, Czech Republic
- 700 1_
- $a Heger, Zbynek $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, 613 00, Czech Republic $u Central European Institute of Technology, Brno University of Technology, Brno, 602 00, Czech Republic
- 700 1_
- $a Wu, Wenda $u MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing, 210095, China. wuwenda@njau.edu.cn $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 50003, Hradec Kralove, Czech Republic. wuwenda@njau.edu.cn
- 700 1_
- $a Kuca, Kamil $u Department of Chemistry, Faculty of Science, University of Hradec Kralove, 50003, Hradec Kralove, Czech Republic. kamil.kuca@uhk.cz
- 700 1_
- $a Adam, Vojtech $u Department of Chemistry and Biochemistry, Mendel University in Brno, Brno, 613 00, Czech Republic. vojtech.adam@mendelu.cz $u Central European Institute of Technology, Brno University of Technology, Brno, 602 00, Czech Republic. vojtech.adam@mendelu.cz $1 https://orcid.org/000000028527286X $7 xx0064599
- 773 0_
- $w MED00165458 $t Journal of hematology & oncology $x 1756-8722 $g Roč. 15, č. 1 (2022), s. 77
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35659268 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134525 $b ABA008
- 999 __
- $a ok $b bmc $g 1821905 $s 1169304
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 15 $c 1 $d 77 $e 20220603 $i 1756-8722 $m Journal of hematology & oncology $n J Hematol Oncol $x MED00165458
- GRA __
- $a 31972741 $p Natural Science Foundation of Jilin Province
- GRA __
- $a 2016T90477 $p Postdoctoral Science Foundation of Jiangsu Province
- GRA __
- $a 759585 $p H2020 European Research Council
- LZP __
- $a Pubmed-20220720